Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468
2019 ◽
Vol 29
(1)
◽
pp. 62-65
◽
2019 ◽
Vol 29
(24)
◽
pp. 126752
2021 ◽
Vol 11
(4)
◽
pp. 354-357
2019 ◽
Vol 120
(10)
◽
pp. 18104-18116
◽
2012 ◽
2012 ◽
2016 ◽
2019 ◽
Vol 177
(2)
◽
pp. 345-355
◽
Keyword(s):